The one thing about this result is that it occur drugs that specific defects.

The one thing about this result is that it occur drugs that specific defects , which opens with the BRCA1 mutation , and this kind of result the possibility of targeted drugs to genetics can target. ‘.

Once genetic testing is faster and cheaper at a higher in a position at a higher risk of prostate cancer to identify and monitor from an early age these people. .Conflict with large trials the 2009 of the value of PSA screening in males have many questions to whether of testing leading to unnecessary interventions experts are unanimous that prostate cancer often over handled, resulting in a. Valued $ 3 billion in in the undue health expenditure annually.

The experts on the panel concluded that there will still much about accomplished in fostering diagnosis and treatment options for prostate cancer. Cancer is the most common non – skin cancer in the Americas and relates to one to 6 male. In 2009, more than 192,000 men have diagnosed with prostate cancer, and more than 27,000 humans died of disease. A new case shall enter every 2.7 minutes and a husband dies prostate cancer all 19 of minutes. It is estimated that exceed 2 million American men currently live with prostate cancer.

Other articles from category "ultrasound":

Random articles